News
Procedure deemed unnecessary in most DVT patients
Researchers have found evidence to suggest that pharmacomechanical catheter-directed thrombolysis is largely inappropriate as first-line treatment...
News
Gene-based Zika vaccine proves immunogenic in healthy adults
An experimental Zika vaccine is safe and induces an immune response in healthy adults, according to research published in The Lancet....
News
Gene therapy seems safe, effective in hemophilia B
The gene therapy SPK-9001 has produced positive results in a phase 1/2 trial of adults with hemophilia B, according to researchers. SPK-9001...
News
FDA lifts partial hold on nivolumab trials
The US Food and Drug Administration (FDA) has lifted the partial clinical hold placed on 2 trials of the PD-1 immune checkpoint inhibitor...
News
Company launches digital PCR test for monitoring CML
Bio-Rad Laboratories, Inc., has launched the QXDx BCR-ABL %IS Kit, a digital polymerase chain reaction (PCR) test that can monitor molecular...
News
Enzyme may be target for MM treatment
The enzyme ADAR1 may be a therapeutic target for multiple myeloma (MM), according to research published in Nature Communications. Investigators...
News
Health Canada approves midostaurin for AML
Health Canada has approved use of the multi-targeted kinase inhibitor midostaurin (Rydapt™). This makes midostaurin the first targeted therapy...
News
Companies launch generic busulfan in US
Two companies have announced the US launch of a generic busulfan product, Myleran Injection. Mylan NV and Aspen have partnered to develop Myleran...
News
System helps predict RFS, OS in BCP-ALL
Researchers say they have developed a more accurate risk scoring system for children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL)...
News
FDA approves use of heparin products
The US Food and Drug Administration (FDA) has approved use of Mylan NV’s heparin products. This includes Heparin Sodium Injection at 1000 USP/mL...
News
Cell-free DNA kit receives CE-IVD mark
Vela Diagnostics’ Sentosa® SX Cell-free DNA (cfDNA) Kit has received the CE-IVD mark, which means this kit is approved for in vitro diagnostics...
News
Antimalarial could aid treatment of ALL
An antimalarial drug and a BH3 mimetic have demonstrated promise for treating BCR-ABL-positive acute lymphoblastic leukemia (ALL), according to...
News
Plek2 may be therapeutic target in MPNs
New research suggests plecktrin-2 (Plek2) may be a therapeutic target for myeloproliferative neoplasms (MPNs). Plek2 was previously shown to be...
News
Drug receives fast track designation for FLT3+ rel/ref AML
The US Food and Drug Administration (FDA) has granted fast track designation to crenolanib for the treatment of patients with FLT3 mutation-...
News
Combo prolongs survival in lymphoma models
Combination treatment with 2 monoclonal antibodies (mAbs) has demonstrated preclinical efficacy against B-cell lymphomas, according to researchers...